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Abstract
Aims and objectives: This paper describes a pilot non-randomised controlled study of a highly tailored 56-day
text messaging and smartphone app prototype intervention to increase adherence to anti-hypertensive medication
in primary care. The aim of this study was to evaluate the acceptability of the intervention and obtain patients’
views about the intervention content, the delivery mode, and the mechanisms by which the intervention
supported medication adherence.
Methods: Patients diagnosed with hypertension were invited and recruited to the study via general practice text
messages and attended a face to face meeting with a member of the researcher team. Participants were asked to test
the text messaging intervention for 28 consecutive days and switch to the smartphone app for 28 more days. Participants
completed baseline and follow-up questionnaires and took part in semi-structured telephone interviews. Digital log files
captured patients’ engagement with the intervention. Participant transcripts were analysed using thematic analysis.
Descriptive statistics were used to summarise data from questionnaires and log files. A mixed methods analysis generated
data to respond to the research questions.
Results: Seventy-nine patients expressed interest to participate in this study, of whom 23 (64% male, 82% above 60 years
old) were registered to take part. With one drop-out, 22 participants tested the text messaging delivery mode (with 20
being interviewed) and four of them (17%) switched to the app (with 3 being interviewed). All participants engaged and
interacted with the text messages and app notifications, and all participants found the intervention content and delivery
mode acceptable. They also self-reported that the interactive elements of the intervention motivated them to take their
medications as prescribed.
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Conclusion: This study provides evidence that the digital intervention is acceptable by hypertensive patients recruited in
primary care. Future research could usefully investigate its feasibility and effectiveness using rigorous research methods.
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Key messages
 The acceptability of a digital intervention,
combining text messaging service with a
smartphone app, to support medication adherence
in patients with hypertension in the UK primary
care, has not been evaluated.
 This pilot study proved that the digital intervention
is acceptable among patients with hypertension, and
it recommended that an interactive intervention to
enable patients track health-related behaviours
might be the way forward to provide personalised
and highly tailored advice and support for adherence
in primary care.
 Future trial should investigate the feasibility of the
digital intervention to support medication adherence
and associative blood pressure in patients with
hypertension, as an adjunct to usual care
consultations.
Introduction
In England, over 12.5 million people are diagnosed with
hypertension (high blood pressure) [1]. High blood pres-
sure is a major risk factor for morbidity and mortality
[2]. Taking anti-hypertensive medication as prescribed
can significantly reduce these risks [3]; however, a sub-
stantial proportion of patients do not take their medica-
tion as prescribed. A recent meta-analysis showed
that 41% of people do not adhere adequately to anti-
hypertensive medications, i.e. they take less than 80% of
their prescribed tablets [4]. Non-adherence contributes
to increased hospital admissions, additional consulta-
tions, referrals, investigations, and medicine wastage. Im-
proved adherence could save of just over £100 million
per year; thus, the Department of Health recommends
that novel interventions for medication adherence
should be developed and tested [5].
Non-adherence to prescribed medication may occur
for a number of reasons, like patients forgetting or miss-
ing a dose or a day of their medication. These reasons
are described as non-intentional non-adherence (NINA)
or intentional non-adherence (INA) [6]. Interventions
are likely to be more effective to support medication ad-
herence, when they address either or both of these de-
terminants by providing highly tailored advice to the
individual [7]. Tailored interventions include behaviour
change techniques (BCTs) mapped onto these key deter-
minants. BCTs are assumed to be the ‘active ingredients’
of behavioural interventions [8]. For example, INA can
be addressed by reinforcing positive beliefs about taking
medications (e.g. ‘keep control of your blood pressure
today by taking all your tablets as prescribed’) and by
countering negative beliefs and concerns (e.g. ‘please do
not forget to take your tablets, even when you do not
have any symptoms. Pills have been prescribed to lower
your blood pressure’). NINA can be addressed through
explicit and implicit reminders [9]. Both NINA and INA
can be addressed by simple query messages to report be-
haviour (e.g. ‘have you taken your medications as pre-
scribed during the past 7 days?’).
Digital interventions like text messaging and down-
loadable applications on smartphones (apps) are promis-
ing ways to provide advice, reminders, and
encouragement, and to support patients to take their
tablets as prescribed. Our recent meta-analyses sug-
gested that automated telephone-based interventions, in-
cluding text messaging interventions [7] and apps [10],
double the odds for adherence to medication prescribed
for long-term health conditions. Our recent feasibility
trial found that digital interventions, including text mes-
saging, can provide highly tailored advice to address ei-
ther or both NINA and INA for medication adherence
and is feasible and potentially effective adjunct to pri-
mary care consultations [11]. However, there is no inter-
vention that has combined text messaging with a
smartphone app, both to maximise the reach of the
intervention and to utilise the advantages of the auto-
mated tracking technology embedded into smart-
phone apps when facilitating a highly tailored behaviour
change intervention.
Based on our previous promising findings [11], we have
developed a 56-day prototype intervention, which we call
PAM (Programme on Adherence to Medication), deliv-
ered by a text messaging service followed by a smartphone
app. This pilot study aimed to pre-test its acceptability to
support medication adherence in patients with hyperten-
sion in primary care. To our knowledge, no other text
messaging followed by a smartphone app intervention has
been pre-tested to address non-adherence to medication
in the UK primary care setting.
Qualitative and quantitative data was integrated into a
mixed methods analysis to answer the primary research
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question of this pilot study: is an individually tailored
text messaging service followed by a smartphone app ac-
ceptable to support medication adherence by pa-
tients treated for hypertension in primary care? Our
secondary research questions were to explore the accept-
ability of the intervention content and delivery mode
functionalities, and the mechanism by which these might
have influenced medication-taking behaviour.
Methods
Recruitment methods and procedure
Three primary care practices were recruited in this
study, which were located in East of England and at di-
verse deprivation areas. Patients were deemed eligible to
participate in this study if they (a) had a diagnosis of
hypertension or high blood pressure, (b) were prescribed
at least one anti-hypertensive medication for a duration
of at least 3 months before recruitment, (c) be had
poorly controlled hypertension (e.g. readings of blood
pressure > 140/90 mmHg recorded in practice databases
during a period of 6 months before recruitment), (d)
were aged 18 years or older, (e) had a good understand-
ing of English, (f) owned and regularly used a mobile
phone, and (g) had the capacity to provide informed
consent. We aimed to recruit 25 participants to respond
to our research questions.
Across the three recruited practices, a total of 1340 pa-
tients eligible to take part in this study were identified
from practice records. A member of the practice staff
sent one text message invitation to all eligible patients.
The invitation included a link to access the study mater-
ial, and to register interest to participate, online. In total,
79 patients responded to the text message invitation
with an interest to participate during the first week from
the day invitations were sent, 54 of whom in the first 2
days. From those, the first 23 patients who met all the
eligibility criteria to participate were enrolled in the
intervention during a baseline meeting with a member
of the research team. During the baseline meeting, a
member of the research team obtained written informed
consent and facilitated the collection of baseline data.
Two researchers conducted the recruitment meetings
from January until March 2019.
Intervention
Participants were provided with the 56-day prototype
intervention, which involved text messaging support for
28 days and then switching to the smartphone app for
the consecutive 28 days. All patients were asked whether
they would like to switch from the text messaging to the
app intervention, after they have completed the text
messaging intervention. The app intervention was com-
patible with android phones only.
Participants received daily reminder messages with ex-
plicit advice (e.g. ‘please do not forget to take your medi-
cation today: amlodipine, 2 tablets, 5mg’), daily advice
messages (e.g. ‘the health benefits of taking your meds
regularly is having low blood pressure. Please keep look-
ing after yourself by taking your medications’), and query
messages (e.g. ‘have you taken all your prescribed meds
in the last 7 days/ today? Reply Yes or NO’). The app in-
cluded additional functions; provided participants with
an option to request and receive feedback on behaviour
and to change the delivery of the intervention messages.
The app tracked medication related routines without
feedback to the patient.
Data collection methods and procedure
Data were collected using questionnaires, telephone in-
terviews, and digital log files.
Questionnaires
The questionnaire included questions regarding patients’
intention to adherence and beliefs about taking medica-
tion. Intentional (INA) and non-intentional non-
adherence (NINA) was measured using the 5-item MARS
questionnaire [12], and beliefs about adherence were mea-
sures using 10 items measuring necessity beliefs (e.g. ‘If I
were to take all my medications as prescribed without
missing a day it would do more harm than good’), control
beliefs (e.g. ‘taking my medications as prescribed keeps my
blood pressure under control’), affective attitudes (e.g.
‘taking my medications as prescribed every day without
missing a day is pleasant/unpleasant/neither’), social
norms (e.g. ‘If they were prescribed tablets, most people
whose opinion I value, would take all their prescribed tab-
lets without missing a day’), copping self-efficacy (e.g. ‘I
take all my medications as prescribed without missing a
day, even if I am busy at home’), and generic emotional
state (e.g. ‘How much of the time during the past month
have you felt calm and peaceful’). The tailoring question-
naires were adapted from, and developed based on our
previous studies [11, 13]. Patients’ answers to these ques-
tions were used to tailor the content of the advice
messages.
The questionnaire at baseline collected information
about patients’ prescribed medications (e.g. name of
medications and dosage), and about the delivery of the
intervention i.e. preferred time to receive the interven-
tion messages. Patients’ answers to these questions were
used to tailor the content of the reminder messages.
Patients completed questionnaires at baseline and
at follow up. Baseline questionnaire collected informa-
tion about patients’ demographic characteristics. Follow
up questionnaires obtained views about the acceptability
of the intervention. Baseline questionnaires were com-
pleted by patients during the meetings with a member of
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the research team and follow-up questionnaires were
complete using an online webpage, which was emailed
to patients.
Interviews
Semi-structured interviews were chosen to obtain in-
depth accounts of participant experiences, thoughts, and
beliefs. Detailed answers were provoked by the re-
searcher, who used open-ended questions and prompts
to explore participants’ experiences with using the inter-
vention [14].
During the interviews, a member of the research team
used a semi-structured interview guide to prompt pa-
tients’ views about the intervention content and delivery
modes, and obtain recommendations for improvement
(please see Appendix 1 and Appendix 2 for the semi-
structured interview guide). Each participant was pro-
vided with the option of a weekly 15-min telephone in-
terviews or one follow up 45-min telephone interview.
Seventeen patients opted for the weekly calls, and the
other five for the interview at the end of the trial. Inter-
views were audio recorded, and the audio files were
transcribed by a third-party company. Patients who
could not attend the interviews (n = 1) provided their
feedback using emails. Interviews were conducted from
February until April 2019.
Weekly data collection was selected to capture partici-
pant thoughts and opinions within its present context as
opposed to potentially weeks later, thus deriving more
detailed, richer data from each participant. Regular data
collections also aimed to identify and solve any technical
issues that may arise when piloting an innovative digital
intervention.
Digital log files
The engagement with the intervention was captured by
digital log files. Digital log files captured the intervention
content participants received and interacted with (e.g.
reported whether or not the medication was taken,
check feedback on adherence to medication, used app
settings to tailor message delivery). Additionally, digital
log files captured medication related routines. The log
files are documents detailing each participants’ recorded
actions and responses whilst using the intervention and
were utilised as objective measure of intervention usage
and engagement. Data from log files were extracted by a
member of the research team.
Analysis
Two members of the research team used thematic ana-
lysis and analysed all interview transcripts independ-
ently. The coding for emerging themes was deductive
and aimed to provide answers to our research questions.
Inductive themes were considered as recommendations
for improvement. The two researchers compared notes
and codes for each interview transcript and made a mind
map to visually link quotes and codes to one another.
The two researchers discussed in-depth themes that had
emerged from the data. Nvivo software was used to fa-
cilitate data analysis.
Data from log files were coded by a member of the re-
search team and integrated into the analysis. Data obtained
from questionnaires and digital log files were summarised
using descriptive statistics. A mixed method approach was
used to synthesise quantitative and qualitative data to pro-
vide answers to our research questions [15].
Results
Seventy-nine patients answered to the text message invi-
tation and expressed their interest to participate in the
study (5.9% response rate to invitation), of whom the
first 23 patients attended baseline meetings and provided
written informed consent to participate. All 23 initially
recruited patients completed the baseline questionnaire
(100% completion rate), which included the tailoring
questions and measured medication adherence. One pa-
tient dropped out of the study before registering with the
intervention due to personal reasons. In total, 22 partici-
pants enrolled in the intervention: all registered with
the intervention for 28 days using the text messaging
service, four of them (17%) selected to switch to the app,
and two installed the app and used the intervention for
56 consecutive days (see Fig. 1).
Twenty patients (out of the final 22 participants) com-
pleted the follow-up interviews (90.9% response rate),
and 19 completed the follow-up questionnaires (86%
completion rate). Participants were 64% men and 82%
above 60 years old (see Table 1).
Fig. 1 Study flow chart
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The data analysis generated results in three main
themes to provide answers to our research questions:
1. Acceptability and usage of the components (i.e.
content and delivery functionalities) of the
prototype digital intervention to patients prescribed
medications to treat high blood pressure
2. Mechanisms by which these components might
have supported medication adherence
3. Recommendations to improve the acceptability of
the intervention
Acceptability and usage of the digital intervention in
patients with hypertension
All participants interviewed (n = 20) reported that the
text messaging service was easy to use (see Table 2
quote 1 and Fig. 3). Similarly, patients who used the app
reported the app functionalities were easy to navigate
(see Table 2 quote 2 and Fig. 3).
Reminder messages
Commenting on the reminder messages, one participant
thought the simple message sufficed and also allowed
for the participant to ‘double-check’ that they had taken
their medication that day (see Table 2 quote 3). Most
participants reported the reminder messages as accept-
able and a positive aspect of the digital intervention (see
Figs. 2 and 3). However, few participants reported dislik-
ing the frequency of the daily reminder messages, with
one participant finding them overbearing. To overcome
this challenge, participants recommended that the inter-
vention should include more options for participants to
Table 1 Practice (n = 3) and participants’ (n = 22) characteristics
Practice area Index
of Multiple
Deprivation ranka,
patients with
hypertension/doctor
ratiob, patients
with hypertension
/staff ratio
(excluding doctors)c
Participants
Patient ID Age bracket Gender Participated at follow-upd
7, 11350/5, 11350/10 1 70–79 Male Yes
2 60–69 Female No
3 30–39 Female Yes
4 60–69 Male Yes
5 50–59 Female Yes
6 50–59 Female Yes
7 70–79 Male Yes
8 70–79 Male Yes
9 60–69 Male Yes
10 70–79 Male Yes
11 70–79 Male Yes
12, 13445/6, 13445/8 12 40–49 Female No
13 60–69 Male Yes
14 60–69 Female Yes
15 60–69 Female Yes
16 60–69 Male Yes
17 70–79 Male Yes
18 60–69 Male Yes
12, 3553/7, 3553/13 19 60–69 Male Yes
20 70–79 Female Yes
21 70–79 Male No
22 60–69 Male Yes
aThe Index of Multiple Deprivation in England, ranks from 1 (most deprived area) to 100 (least deprived area)
bIncludes GPs
cIncludes nurses, health practitioners, and healthcare assistants
dIf a participant provided complete data at follow up. 'Yes' inidicates completion, 'No' indicated non completion
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Table 2 Thematic analysis results
Theme 1. Acceptability of the digital intervention for patients diagnosed with high blood pressure
Quote Participant ID, age, and tested
delivery mode
1 “No, no, everything was straightforward really. There was nothing at all that stood out as being awkward
about it, or difficult.”
Participant 7, M, age 70–79, text
2 “Logical, smooth interface, easy to navigate.” Participant 9, M, age 60–69, text
and app
3 “No, it’s just a straightforward message, have I taken all my meds? Which I suppose if I hadn’t, it would
have made me think, well have I?”
Participant 1, M, age 70–79, text
4 “P: It’s almost patronising”
“I: Okay, so do you have any suggestions of how we might try and change that so it’s not so as annoying
or patronising?
P: Well maybe less frequency”
Participant 16, M, age 60–69, text
5 “Because it’s a different that was every day, you know it’s not going to be the same message so you’re
going to pay attention and read it, and reading it should reinforce in your mind ah, I need to take my
tablets.”
Participant 9, M, age 60–69, text
and app
6 “This tab (with feedback on behaviour), for me personally, did I stick to the right times, how far off was I,
how was I on, do you know what I mean? That sort of information, for me, would have been yes, great.
Say after about a week or a month you could look and think what’s going on here?”
Participant 18, M, age 60 to 69,
text and app
7 “I: Would you have any reservations about us using GPS data?
P: None at all. I think that’s probably better than messages coming through when you’re out and when
you’re driving or shopping, say you say. It’s rather intrusive. If anything comes through when I’m driving, it
has to wait until I’ve finished driving. I don’t even acknowledge it.”
Participant 1, M, age 70–79, text
8 “Simply because the greater the likelihood of getting the message, I don’t know, would equivocally
improve delivery of the message.”
Participant 14, F, age 60–69, text
Theme 2. Mechanisms by which the digital intervention has supported medication adherence
Quote Participant ID, age, and tested
delivery mode
9 “I: So, it makes you think back onto the past week and reflect?
P: Yes, yes. And you think, let me look at my tablets, to see if there’s as many left as there ought to be?”
Participant 1, M, age 70–79, text
10
“Whereas, if it goes off in your pocket and you think I will get it after, but about 5 o’clock or something it
goes off in your pocket and you think oh, I better get this. Have you taken your medicine? No, I haven’t,
so then I’ve got to then go upstairs, view it and then press yes. So, then it’s forced on me, if you like, to
make sure I do take it.”
Participant 18, M, age 60 to 69,
text and app
11
“I was waiting for the alarm to go off. Then it was about 20 minutes late, but I was already there with the
tablets to take anyway. So, it’s made me take them, even though I didn’t get the alarm at eight o’clock, if
you see what I mean. So, that was fine. So, I had taken them anyway because that’s made me more
aware that I should take them at that time rather than any time, at random times.”
Participant 15, F, age 60–69, text
12
“P: Well, yes just exactly what I mean, being committed to take your tablets as prescribed because it’s for
your own benefit.”
Participant 1, M, age 70–79, text
13
“I do think it does help if people feel as though they’re involved (with taking their medications)” Participant 20, F, age 70–79, text
14
“To me, that’s saying have you taken it yes or not, I suppose you could lie about it but if you’re going to
do that what’s the point of having the text message, I don’t see the point. But yes, it’s an interactive thing
isn’t it? So, you’re taking ownership, if you like and dealing with it that way.”
Participant 18, M, age 60 to 69,
text and app
15
“P: What’s the next one? ‘Tablets are part of your self-care.’ I think that was the last message. It’s a re-
minder that the ultimate responsibility lies with yourself, so take ownership… People don’t take enough
personal responsibility. So, if you like, that was quite a good reminder – well actually your meds are down
to you and nobody else. You are prescribed them, but you’ve got to take them.”
Participant 9, M, age 60–69, text
and app
16
“If you just get a reminder all the time and it goes off in your pocket, you think it’s just a text, I’ll answer it
later. If you think that oh, that could be about my medication and I’m going to have to respond yes or
no, then you take it out and you’re going to look at it and you’re taking ownership of your responsibility
obviously it’s your anyway for taking your meds.”
Participant 18, M, age 60 to 69,
text and app
17
“I: Okay, is there anything else that you wanted to speak about regarding the messages at all, like the
query message style message?
P: No, no. Like I say, I think, to have that, sort of, as a summary of how has the week gone? Have you
taken your tablet? Yes. Well done. And, like I say, in a strange sort of way, it’s very motivational.
I: Well that’s good. So, did it motivate you, and how did it motivate you?
P: Well I think you sort of smile when you get the ‘Well done’ and (inaudible 00:10:19) the following week.
Participant 13, M, age 60–69, text
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Table 2 Thematic analysis results (Continued)
And I actually did manage to take my tablet every day, on time. So, it just sort of … it’s like an added
encouragement.”
18
“But yes, it’s an interactive thing isn’t it? So, you’re taking ownership, if you like and dealing with it that
way.”
Participant 18, M, age 60 to 69,
text and app
19
“I think the advice part is like kind of key, but also I think, even though it's text message and it limits you
to characters, but I think giving succinct points, people are more likely to read them, so maybe on the
advice have one topic a week and every day, come up with a different aspect of that topic”
Participant 5, F, age 50–59, text
Theme 3. Recommendations to improve the acceptability of the digital intervention
Quote Participant ID, age, and tested
delivery mode
20
P: Well, the negative sides makes you think oh god, you know, you start to get a little bit thinking that oh,
…. if you see what I mean, but not, you know, but if it’s then positive, you think yes, that’s why I need to
take them.
Participant 15, F, age 60–69, text
21
“I: If you were designing the service, was there anything that you would do differently?
P: Well, the only thing that I could suggest would be, although it might be a bit long-winded, if you’ve
got morning medication and evening medication that you would perhaps need, like I’ve said before, be
more likely to forget the evening one than the morning one because it’s not in my routine so much. But
I didn’t get a message for the evening one, so could possibly need a message for both situations.
I: Okay. And would you want those messages to come through separately at the times you take your
medication, or would you want one sort of big text message in the morning reminding you of all the
medications that you need to take that day?
P: Yes, it would have to be at different times, I suppose, because if I had a message about the morning
one and the evening one in the morning, I’m still likely to forget if I was going to in the evening one. So,
you’d need two messages a day and I suppose if you’re going to be taking lots of things at different
times that might become a little troublesome, I suppose.”
Participant 22, M, age 60–69, text
22
“And they have am and pm on them, or lunch time one as well. So, you could do it three times a day
because most people it is only three times a day for medication. Morning, lunch time, and evening, isn’t
it?”
Participant 6, F, age 50–59, text
23
“I: So, if the reminder came through at a time where
you couldn’t take your medication, did you just press
no or did you use the snooze button to snooze?
P: To be honest, on the app?
I: Yes, on the app?
P: I didn’t know there was one. I never saw that.”
Participant 18, M, age 60 to 69,
text and app
24
“I think help-wise, like a how to maybe, because it’s obviously complicated, a how to guide maybe, that
could probably help.”
Participant 18, M, age 60 to 69,
text and app
25
“I didn’t really understand, like looking at this (feedback on behaviour) tab and bits and pieces like that
…”
Participant 18, M, age 60 to 69,
text and app
26
“I: Do you wish that we maybe used a bar chart, maybe something more visual or was it okay for you?
P: No. well, everybody is different, aren’t they? Some people prefer, some people learn by visualise, look at
it, other people like the colours, like the graphs, other people prefer data as it’s written down.”
Participant 18, M, age 60 to 69,
text and app
27
“P: Probably because, I mean I much easier to just do it on a daily basis becomes sometimes you can be
forgetful, unless you write it down, I don’t know. Maybe it might make people anxious about their
memory and stuff like that, I don’t know. As much as it has a clinical purpose, why do you need to ask
them at the end of the week when it’s just better to ask them every day since their short-term memory is
probably much more reliable?
I: Yes, that’s true. So, you would suggest asking, having that query message sent every day instead of
once at the end of the week?
P: Yes.”
Participant 14, F, age 60–69, text
28
“P: I’d probably put a bit less advice in, it might get a bit boring after a while, it’s okay the first week they
were all different, I’m sure that if that goes on for months and months and months you’d have to repeat
some of them quite regularly.
I: So, less frequent advice messages?
P: All I really would need is a reminder.
I: So, the reminder every day and how often would you have the advice message come through?
P: Probably once a week would be good.”
Participant 11, M, age 70–79, text
29
“The advice. Not the one reminding you to take your medication, the other one after that. Maybe once or
twice a week would be alright, to put something like that out. But getting that every day, seemed to be a
little bit too much really…. No. I just think, at my stage, to keep getting advice messages like that, it
would lose the point of it, it would lose its impact then ... I just think if it was less frequent, then maybe it
would have more of an impact.”
Participant 7, M, age 70–79, text
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reduce the frequency of receiving these messages, espe-
cially if the intervention was of a longer duration (see
Table 2 quote 4). Both app patients have used the
snooze functionality of the app to re-schedule the time
of the reminder messages (see Table 3).
Advice messages
Participant opinions on the advice, non-reminder, messages
were much more variable (see Fig. 2). For example, one
participant suggested that the advice messages increased his
attention to read the messages and in turn increased his
motivation to take his medication as suggested (see Table 2
quote 5). This may be due to receiving a variety of advice
messages throughout the digital intervention, with each
message emphasising and addressing a different reason
regarding medication adherence. Data from digital log files
suggested that participants who used the app acknowledged
or dismissed the receipt of all advice messages.
Query messages
Furthermore, the ‘query’ message was sent to participants
asking them to reply ‘yes’ or ‘no’ as to whether they had
taken all their prescribed medication. Participants were
asked to respond to the query message one per week
(when testing the text messages) or when each medication
was taken (when switching to the smartphone app). The
concept of the query message arose from the behaviour
change strategy of ‘reporting whether or not the behaviour
was performed’ [7, 11, 16]. All participants reported to
query messages and most reported that they liked these
Table 2 Thematic analysis results (Continued)
30
“What I don’t have any problem with is somebody who comes up front and says this app is going to do
and it’s going to watch where you go because, because, because. So, yes, I have concerns, but as you’ve
explained that, I have no concerns at all because you’ve been upfront about it.”
Participant 9, M, age 60–69, text
and app
31 “I: Okay, so is it that NHS name or that label of the NHS that makes you think (it's secure)?
P: I think it would be the label.
I: So, the labelling of the NHS makes you feel a lot safer with the data?
P: Yes.
I: Okay, similar too, would you feel the same if it was the University of Cambridge logo instead of the
NHS?
P: I don’t see why not. I don’t see it being a problem, because I mean you’re with them now and we’re
discussing it aren’t we, so I don’t think that would be a problem. It might be for some people.”
Participant 15, F, age 60–69, text
32
“I personally think, because I’m 70 next year, but in my head, I’m only 50, if you know what I mean. But a
lot of people who are my age are forgetful. So, if you’re leading a busy life, I would say at least six weeks,
and I’m in week three, but because I get up early in the morning and everything, I’m busy doing things, I
tend to forget if I’m sitting in front of the television or something. So, yes, I think six weeks would be a
good routine because as I said, I’ve done it in three where I’ve been, oh god, I must take my tablets, it’s
eight o’clock. So, I personally think perhaps six weeks would make them more aware that they should be
doing this, and that would built a routine.”
Participant 15, F, age 60–69, text
33
“P: So, you don’t feel as if actually they do take care with what’s happening. It sounds very negative, I
don’t mean it quite like that, but I think it’s just a question that they probably would feel worthwhile and
that someone understands that they are taking tablets you see. Because I never see the same doctor.
I: So, do you think that this service could maybe help to counteract some of those feelings of being…?
P: Oh yes, definitely.”
Participant 15, F, age 60–69, text
Fig. 2 Satisfaction with the intervention. N = 19 patients. Data collected by follow-up questionnaires
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messages (see Table 3 and Fig. 2). All participants received
the query messages and the response rate, to both text
message and app notifications, was 100%, and this engage-
ment score was maintained throughout the intervention,
indicating high participant engagement with the digital
intervention and acceptability of these messages to sup-
port medication adherence.
Participant discussed the benefits of the ‘feedback on be-
haviour’ functionality on the app, which generates a per-
centage score of patients’ self-reported medication
adherence over the past day and week (e.g. ‘you’ve reported
that you have taken 89% of your prescribed medication last
week’). Participants found this intervention content inform-
ative and reported using it to self-monitor their medication
adherence and to reflect on their patterns regarding their
medication-taking routine (see Table 2 quote code 6). Both
app users requested the feedback on their self-reported be-
haviour by checking the app functionality, in most cases
after they have self-reported medication adherent behaviour
(see Table 3).
Functions to tailor message delivery
This function provides the participant with options to
re-schedule the frequency (e.g. by texting 'less' to receive
less messages or 'more' to receive more intervention
messages) and the time of the reminder messages (e.g.
by snoozing the reminder notifications). Participants tai-
lored the delivery of the reminder messages on average 5
times when using the smartphone app, and none when
using the text messages. This function was found useful
to those participants who reported that were busy at the
time the reminder message appeared and could not re-
spond confirming whether or not they have taken their
tablets. Patients have also the option to set and re-
schedule the time and date of their refill prescription re-
minders, and both patients set their refill reminders and
used the app function to re-schedule the time and day of
the refill reminder notification on average 7 times, during
4 weeks (see Table 3). In all occasions, they tailored the
delivery of the reminder messages successfully, implying
the importance of including this function in the app, as
well as how easy it is to use it. Some participants sug-
gested that the option to tailor the delivery of the refill re-
minder notifications increased the acceptability of the
intervention.
Acceptability of tracking medication related routines using
the smartphone technology
All participants were asked about their views about the
app using the GPS, Wi-Fi, and accelerometer embedded
on their phone, to automatically track their behaviours
related to medication taking during the intervention. All
Fig. 3 Acceptability of the intervention as an adjunct to usual care. N = 19 patients. Data collected by follow-up questionnaires
Table 3 Intervention engagement per delivery mode
Text messages Frequency
Report whether or not the behaviour was performed 72
App
Report whether or not the behaviour was performed 52
Feedback on behaviour
Daily 15
Weekly 9
Tailor messages delivery
Snooze reminder messages 5
Update refill reminder day and time 7
Engagement with the intervention for the duration of 28 days. N = 22 patients
for the text messaging. N = 2 for the smartphone app, after the text
messaging intervention. Data extracted by digital log files
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participants reported having no concerns over the secur-
ity of their behavioural patterns related to medication
adherence being captured through the app sensing tech-
nology. Some of them have also suggested that tracking
technology could make daily medication taking effortless
and easier (see Table 2 quotes 7 and 8). They also sug-
gested that the information about their medication tak-
ing routines, collected by smartphone technology, could
be utilised during consultations with health care pro-
viders to improve medication adherence.
Mechanisms by which the intervention has supported
medication adherence
For some participants, receiving the query message was
an opportunity to reflect on their medication-taking be-
haviour and raise their awareness as to whether or
not they had taken all the doses of the medication they
were prescribed (see Table 2, quotes 9, 10, and 11, and
Fig. 3). This strategy seemed to have motivated medica-
tion taking through several ways: (a) by increasing par-
ticipants’ commitment to reply to the query message, (b)
by raising awareness of tablet-taking routine, (c) by in-
creasing feelings of involvement with their own
medication-taking routine, and (d) by empowering them
to take their medications as prescribed (see Table 2
quotes 12, 13, and 14). These findings suggested that
reporting behaviour is a motivational behaviour change
technique, which can lead to increased performance of
the target behaviour.
The importance of accessing feedback regarding medi-
cation adherence behaviour in motivating participants to
change their behaviour, was also suggested by partici-
pants testing the app. Both app testers checked this app
functionality after successfully installing the app (see
Table 3), with one of the participants attempting to view
their adherence report six times in the first day of
switching to the app. This could be explained by an ini-
tial exploration period after first installing the app; how-
ever, both participants continued to check the
functionality with feedback on behaviour at least once a
day for 4 days after switching to the app. These findings
imply that participants find this function interesting and
an engaging feature of the app and that feedback on the
behaviour might be important to increase patients’ mo-
tivation to change behaviour.
It was also found that the tailored daily advice mes-
sages may have caused an increase in the participants’
attention and curiosity when interacting with the inter-
vention, and therefore an increase in engagement with
the intervention. It was also recommended that the tai-
lored advice messages have prompted self-monitoring
and possibly increased acting upon these advice
messages.
A number of participants agreed that the digital inter-
vention may also help to increase patients’ feeling of em-
powerment and ownership of their long-term health
condition, with one participant expressing how he particu-
larly liked one of the advice messages which encouraged
patients to take responsibility for their own medication-
taking routines as a self-care process. Participants reported
that they found the intervention messages particularly
useful because they suported them to establish a sense of
ownership over the condition and motivated them to be
more self-aware of their independent responsibility over
their health condition (see Table 2 quotes 15, 16, 17, and
18).
All participants liked the interactive elements of the
intervention, and reported feeling motivated to continue
taking tablets regularly and as prescribed, after interact-
ing with the intervention (see Table 2 quote 15).
Most participants expressed preferences towards the
advice messages which included positive reinforcement
to take their tablets (see Table 2 quotes 17, 18, and 19).
The preference towards the advice messages came up
multiple times during the interview, specifically in the
context of increasing patients’ motivation to take their
medication to treat hypertension as a self-care process
(see Table 2 quotes 15 and 19).
Recommendations to improve the acceptability of the
digital intervention
All patients reported that they would recommend the
intervention to other people who have been prescribed
medications for long-term health conditions and those
newly prescribed (see Fig. 3). They have also made rec-
ommendations to improve intervention content, deliv-
ery, and implementation procedures.
Many participants suggested receiving separate re-
minder messages for every medication they take each
day. However, many other participants reported patients
who are prescribed multiple daily medications a poten-
tial limitation to this idea, for example sending individ-
ual reminder messages to an individual who takes ten or
more tablets every day will most probably be less accept-
able (See Table 2 quote 20 and 21). However, another
participant recommended a solution to this problem,
suggesting combining the medication reminders into
morning, lunchtime, and evening routines (see Table 2
quote 22).
Furthermore, one of the participants testing the app
reported not using the additional app functions, which
could be used to tailor the delivery of the medication re-
minder until a later time (see Table 2 quote 23). The
participant recommended a help guide with interactive
elements to explain all features of the app and how to
use them when first installing the app (see Table 2 quote
24 and 25). A help guide to aid patients’ navigation
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through the app would potentially increase accessibility
and intervention engagement.
Participants also recommended different ways to sum-
marise the feedback on behaviour, such as graphs or
colour-coded systems and traffic light colour code sys-
tems (green = goal met; orange = room for improve-
ment; red = goal unmet, improvement needed), which
are universally understood and easy to interpret, thus
might be accessible to a range of individuals with varying
learning styles (see Table 2 quote 26).
Moreover, the frequency of the query message was
also discussed between participants; some participants
suggested that responding to the query message every
day would be effortless and thought others would prefer
less frequent queries about medication adherence. How-
ever, another participant suggested receiving a daily
query message, stating that it would help those with
poor memory or those with busy daily routines (see
Table 2 quote 27).
Towards the end of the 28-day intervention, many par-
ticipants suggested once a week, instead of every day,
was an appropriate frequency to receive the advice mes-
sages to improve intervention acceptability and engage-
ment (see Table 2, quote 28). However, one participant
expanded upon this idea and suggested that the impact
of the advice messages might be decreased if received
daily (see Table 2 quote 29). Thus, receiving one or two
advice messages a week would be more acceptable to en-
courage patients to take their prescribed medications
regularly, especially if the intervention was to support
sustained medication adherence.
The tracking functions of the digital intervention could
facilitate effortless medication adherence in the long
term, however to increase its acceptability, a clear and
honest communication is needed to explain the privacy
and the purpose of using tracking data to support medi-
cation adherence (see Table 2 quote 30). Furthermore,
some participants also suggested using the logo of the
NHS or University of Cambridge to visually link the app
to a trusted institution (see Table 2 quote 31).
Overall, participants suggested that the digital inter-
vention could support medication taking daily routines
and be an acceptable adjunct to primary care and in-
crease satisfaction with the health care provided by GP
practices (see Table 2 quotes 32 and 33 and Fig. 3).
Discussion
This mixed methods study suggests that the PAM proto-
type intervention is acceptable by patients with hyperten-
sion and that it may support medication adherence by
improving motivation to take all doses of the pre-
scribed medications as part of a daily routine. It was
found that the content of the highly tailored intervention
was acceptable and that all participants used and
engaged with the intervention. The study also supported
that all patients interacted with the query intervention
messages to support their medication-taking behaviour
and they found the additional tracking functionalities of
the smartphone technology acceptable, with few (17%)
opting to use these additional tracking elements to sup-
port medication adherence.
The high response rate to the messages enquiring par-
ticipant to report about adherence to medication dem-
onstrates a promising projection of engagement that will
be especially important for the future trial of this inter-
vention, to provide information about how intervention
engagement associates with changes in behavioural and
clinical outcomes. Thus, not only do the results of this
study suggest that both the text messaging and app de-
livery modes of the digital intervention are acceptable,
but also that the content of the intervention is accept-
able by patients with high blood pressure. Therefore, the
positive results from this study provide us with confi-
dence to proceed into testing this digital intervention for
feasibility at a randomised controlled trial.
A strength of this pilot study is that it utilised two
digital delivery modes to maximise the reach of a highly
tailored intervention even to those with low digital liter-
acy and to provide with a choice of an automated self-
tracking advice to support medication adherence. To
our knowledge, this is the first intervention that utilised
a combination of text messaging and smartphone app
and has been pre-tested to address non-adherence to
medication within the UK primary care setting. Another
strength of this study was its unique data collection
method of weekly interviews that allowed us to identify
and solve any technical issues more explicitly and
quickly than using the traditional hour-long interview at
the end of the trial. This study also used a mixed
methods analysis and synthesised qualitative and quanti-
tative data from multiple sources to respond to our re-
search questions.
This study is limited by the small number of patients
as well as the short duration of the intervention. An-
other limitation of the study is the small proportion of
patients switching to the smartphone app.
Conclusion
The findings of this study informed the upcoming trial
to evaluate the feasibility of this digital intervention to
support medication adherence and blood pressure to pa-
tients prescribed treatement for hypertension in primary
care. This study provides evidence that this novel digital
intervention is acceptable by patients with hyperten-
sion in primary care. Not only is the content of the
intervention acceptable, but also the two digital delivery
modes were found to be acceptable by patients. This
study also found the digital intervention to be highly
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engaging and supportive to patients. When considering
the high cost medication non-adherence imposes upon
the NHS, this study is of particular importance as it pro-
vides evidence supporting that this low-cost intervention
may be an acceptable answer to help achieve healthcare
priorities.
Appendix 1
Interview schedule for face-to-face interviews with
people with high blood pressure to assess their expe-
riences using the text message delivery mode of the
digital intervention
Interview set-up
 Begin audio recording device
 Ask participant for their consent to be interviewed
about their experiences using the intervention, and
their consent for this interview to be audio recorded
Introduction
 Introduce myself
 Give an overview of the aims of the interview
 Consent issues
 Ask if participants have read the information sheet
and if they have any questions
 If not, overview the information included
 Clarify that they can withdraw from the interview at
any time, without giving a reason
 Clarify that the interview will be audio recorded,
explain the use of transcripts and the confidentiality
issues
Questions to assess participants’ experiences using
the digital intervention
 Did the digital intervention help you to take your
medications as prescribed?
 If yes, in what way?
 If no, can you elaborate on the reasons?
 What did you like most about the digital
intervention?
 Do you ever forget to take your medication or alter
the dose?
 If yes, which medications?
 If yes, how often would you estimate you do not
take your medications as prescribed?
 What might be the reasons for this?
 What did you find difficult about the digital
intervention?
 How did you find the content of the reminder
messages?
 Did you like the personalisation of the text
messages? E.g. name.
 How did you find the content of the advice
messages?
 Do you have any other suggestions for what we may
include in the advice messages?
 Did you find any faults in the text messaging
service?
 Do you have any suggestions for improvements
regarding any features in the text messaging
service?
 How easy was it to reply to the Q&A style questions
on the digital intervention?
 If you were designing the digital intervention, what
would you do differently?
4th Interview
 All of the above questions, plus:
 We’re also developing an app to deliver this service.
Do you think you would use an app version of this
service?
 Who do you think would use the app?
 We could include other features in the app such
as tablet-taking logs, percentage of medication ad-
herence, and a snooze button for the reminders.
Do you think these ideas would be helpful to you
when encouraging you to take your tablets?
 What else do you think would be helpful to include
into the app?
 The app may include ‘sensing data’, which means it
may look at the accelerometer data on your smart
phone, and will not send you messages when you
are exercising. Do you think this is acceptable?
Would you be happy for the app to look at this
data?
 Also, the app could look at when your phone is
connected to your home Wi-Fi and only send you
messages when you’re at home with your tablets.
Would you be happy for an app to do this?
 What are your concerns with the sensing data?
 Finally, would you like to test using the app for one
month?
Appendix 2
Interview schedule for face-to-face interviews with
people with high blood pressure to assess their expe-
riences using the app delivery mode of the digital
intervention
Interview set-up
 Begin audio recording device
 Ask participant for their consent to be interviewed
about their experiences using the intervention, and
their consent for this interview to be audio
recorded.
Introduction
 Introduce myself
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 Give an overview of the aims of the interview
 Consent issues
 Ask if participants have read the information sheet
and if they have any questions
 If not, overview the information included
 Clarify that they can withdraw from the interview at
any time, without giving a reason
 Clarify that the interview will be audio recorded,
explain the use of transcripts and the confidentiality
issues
Questions to assess participants’ experiences using
the app
 Did the app help you to take your medications as
prescribed?
 If yes, in what way?
 If no, can you elaborate on the reasons?
 What did you like most about the app?
 What did you dislike about the app?
 Do you ever forget to take your medication or alter
the dose?
 If yes, which medications?
 If yes, how often would you estimate you do not
take your medications as prescribed?
 What might be the reasons for this?
 What did you find difficult about using the app?
 How did you find answering whether you had taken
your medication every day?
 Was it acceptable to you to answer every day?
 Should we include reasons why you may have not
taken your medication so you can track these
reasons?
 Did you use the snooze button at all?
 Did you find it easy to use the snooze button?
 Is the snooze button a helpful addition to the app?
 Did you like the advice messages coming through
every day?
 Do you have any other suggestions for what we may
include in the advice messages?
 Did you look at your adherence reports?
 Were they easy to understand?
 Did looking at your adherence report change your
motivation for medication adherence?
 What else do you think we could include for
increase motivation to adhere to medication?
 What other reports would you like to see? Reports
of other behaviours? Different style of reports e.g.
pie chart, bar graph, line graph.
 Who do you think would benefit from using the
app?
 If you were designing the app, what would you do
differently?
 What else do you think would be helpful to include
into the app
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